Sirna, conjugate which contain sirna, pharmaceutical composition and uses thereof

WO2026200858A1PCT designated stage Publication Date: 2026-10-01SHANGHAI HANSOH BIOMEDICAL CO LTD +2
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/CN2026/085445
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-14
Filing Date
2026-03-24
Publication Date
2026-10-01

Smart Images

  • Figure PCTCN2026085445-FTAPPB-I100001
    Figure PCTCN2026085445-FTAPPB-I100001
  • Figure PCTCN2026085445-FTAPPB-I100002
    Figure PCTCN2026085445-FTAPPB-I100002
  • Figure PCTCN2026085445-FTAPPB-I100003
    Figure PCTCN2026085445-FTAPPB-I100003
Patent Text Reader

Abstract

Provided is a siRNA molecule that interferes with target gene expression or inhibits its expression. Also provided is a conjugate or a pharmaceutical composition containing the siRNA. Further disclosed is the use of the siRNA, the conjugate or the pharmaceutical composition thereof in preparing a drug used for treating and / or preventing diseases or disorders.
Need to check novelty before this filing date? Find Prior Art